IP Library Assignment 019110/0947
Patent Assignment
Reel/Frame 019110/0947

Assignment of Assignor's Interest

Recorded: 2007-03-29 Pages: 5
Assignors
HASELBECK, ROBERT
Executed: 2006-12-15
HILGERS, MARK
Executed: 2006-12-15
SHAW, KAREN
Executed: 2006-12-13
BROWN-DRIVER, VICKIE
Executed: 2006-12-15
GC, KEDAR
Executed: 2006-12-15
FINN, JOHN M.
Executed: 2006-12-12
STIDHAM, MARK
Executed: 2006-12-15
Assignee
RX3 PHARMACEUTICALS
6310 NANCY RIDGE DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Property (1)
Method for Identifying Drug-Sensitizing Antisense Dna Fragments and Use Thereof
Patent: 7,910,337 →
Application: 11/636,394 →
Publication: US 2007/0218481
Related Assignments (8)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Nov 10, 2009
From: TRIUS THERAPEUTICS, INC.
To: SOFINNOVA VENTURE PARTNERS VII, L.P., AS COLLATERAL AGENT
Reel/Frame 023496/0079 →
Release of Security Interest Aug 26, 2010
From: SOFINNOVA VENTURE PARTNERS VII, L.P.
To: TRIUS THERAPEUTICS, INC.
Reel/Frame 024895/0248 →
Change of Name Jan 28, 2011
From: RX3 PHARMACEUTICALS, INC.
To: TRIUS THERAPEUTICS, INC.
Reel/Frame 025713/0821 →
Security Agreement Nov 13, 2013
From: OPTIMER PHARMACEUTICALS, INC.; TRIUS THERAPEUTICS INC.
To: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
Reel/Frame 031628/0850 →
Release of Security Interest Jul 24, 2015
From: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
To: TRIUS THERAPEUTICS, INC.; OPTIMER PHARMACEUTICALS, INC.
Reel/Frame 036178/0175 →
Change of Name Sep 2, 2015
From: TRIUS THERAPEUTICS, INC.
To: TRIUS THERAPEUTICS LLC
Reel/Frame 036528/0029 →
Nunc Pro Tunc Assignment Sep 3, 2015
From: TRIUS THERAPEUTICS LLC
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036484/0796 →
Merger Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →